EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Detection of TDP‐43 seeds in CSF of presymptomatic and symptomatic genetic FTD/ALS

Ilaria Linda Dellarole, Vittoria Aprea, Marcella Catania, Claudia Battipaglia, Aurora Romeo, Cristina Villa, Anna Burato, Luigi Celauro, Eleonora Dalla Bella, Nilo Riva, Erika Salvi, Giacomina Rossi und 9 weitere

Alzheimer's & Dementia · 2025

DOI: 10.1002/alz.70989 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Alzheimer's & Dementia, 2025. Verfasst von Ilaria Linda Dellarole und 20 weiteren Autor:innen. Beteiligte Einrichtung: SSD Laboratory Medicine-Laboratory of Clinical Pathology, Fondazione IRCCS Istituto Neurologico Carlo Besta, Milan, Italy. Hauptthemen laut MEDLINE: DNA-Binding Proteins, Frontotemporal Dementia, Amyotrophic Lateral Sclerosis. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 32 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Ministero della Salute, JPND, EU Joint Programme – Neurodegenerative Disease Research.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

INTRODUCTION Seed amplification assays (SAAs) have shown promising results in detecting misfolded transactive response (TAR) DNA‐binding protein 43 (TDP‐43) in cerebrospinal fluid (CSF) of genetic frontotemporal dementia (FTD). To date, the use of SAA has yet to be evaluated in presymptomatic individuals. METHODS Thirty patients carrying GRN or C9orf72 mutations, 2 microtubule‐associated protein tau ( MAPT ) carriers, 14 presymptomatic subjects, and 27 controls underwent CSF collection. We used SAA for detecting misfolded TDP‐43 (TDP‐43_SAA) and single molecule array (SIMOA) technology for neurofilament light chain (NfL) dosage. RESULTS TDP‐43 seeding activity was detected in 67% of TDP‐43‐linked symptomatic patients, with a specificity of 93%. Almost half of presymptomatic subjects tested positive, mostly GRN carriers. Interestingly, among TDP‐43_SAA positive presymptomatic individuals, two GRN carriers underwent phenoconversion. DISCUSSION TDP‐43_SAA can also detect misfolded TDP‐43 in the CSF of presymptomatic individuals. A possible link exists between positive TDP‐43_SAA and conversion to the symptomatic phase. Highlights Seed amplification assay of transactive response (TAR) DNA‐binding protein 43 (TDP‐43_SAA) can detect misfolded TDP‐43 in the cerebrospinal fluid (CSF) of patients with genetic frontotemporal dementia (FTD), linked to GRN and C9orf72 mutations. TDP‐43_SAA can detect misfolded TDP‐43 also in the CSF of presymptomatic individuals. In both groups, most TDP‐43_SAA positive cases were carriers of GRN mutation. Two GRN carriers that resulted TDP‐43_SAA positive converted to the symptomatic phase of the disease.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

DNA-Binding ProteinsFrontotemporal DementiaAmyotrophic Lateral SclerosisHumansMaleFemaleMiddle AgedC9orf72 ProteinProgranulinsMutationAgedtau ProteinsAdultBiomarkersNeurofilament Proteins

Stichwörter der Autor:innen

CSFSAATDP‐43amyotrophic lateral sclerosisfrontotemporal dementiaseed amplification assays

Substanzen

DNA-Binding ProteinsTARDBP protein, humanC9orf72 ProteinProgranulinsGRN protein, humanC9orf72 protein, humantau ProteinsBiomarkersNeurofilament Proteinsneurofilament protein L

Autor:innen und Institutionen

  • SSD Laboratory Medicine-Laboratory of Clinical Pathology, Fondazione IRCCS Istituto Neurologico Carlo Besta, Milan, Italy.
  • Neurology 8 - Dementias and degenerative diseases of CNS Unit, Fondazione IRCCS Istituto Neurologico Carlo Besta, Milan, Italy.
  • Laboratory of Prion Biology, Department of Neuroscience, Scuola Internazionale Superiore Di Studi Avanzati (SISSA), Trieste, Italy.
  • Neurology 3 - Neuroalgology Unit, Fondazione IRCCS Istituto Neurologico Carlo Besta, Milan, Italy.
  • Data Science Center and Computational multi-Omics of Neurological Disorders (MIND) Lab, Fondazione IRCCS Istituto Neurologico Carlo Besta, Milan, Italy.
  • Department of Neurology and Alzheimer Centre, Erasmus MC University Medical Centre (Erasmus MC), Rotterdam, The Netherlands.

Förderung

  • Ministero della Salute
  • JPND
  • EU Joint Programme – Neurodegenerative Disease Research

Zitieren

APA

Dellarole, I. L., Aprea, V., Catania, M., Battipaglia, C., Romeo, A., Villa, C., Burato, A., Celauro, L., Bella, E. D., Riva, N., Salvi, E., Rossi, G., Fede, G. D., Legname, G., De Houwer, J. F. H., Alberici, A., Borroni, B., Seelaar, H., van Swieten, J. C., …, & Caroppo, P. (2025). Detection of TDP‐43 seeds in CSF of presymptomatic and symptomatic genetic FTD/ALS. Alzheimer's & Dementia. https://doi.org/10.1002/alz.70989

Vancouver

Dellarole IL, Aprea V, Catania M, Battipaglia C, Romeo A, Villa C, et al. Detection of TDP‐43 seeds in CSF of presymptomatic and symptomatic genetic FTD/ALS. Alzheimer's & Dementia. 2025. doi:10.1002/alz.70989

BibTeX
@article{Dellarole2025,
  author = {Dellarole, Ilaria Linda and Aprea, Vittoria and Catania, Marcella and Battipaglia, Claudia and Romeo, Aurora and Villa, Cristina and Burato, Anna and Celauro, Luigi and Bella, Eleonora Dalla and Riva, Nilo and Salvi, Erika and Rossi, Giacomina and Fede, Giuseppe Di and Legname, Giuseppe and De Houwer, Julie F H and Alberici, Antonella and Borroni, Barbara and Seelaar, Harro and van Swieten, John C and Moda, Fabio and Caroppo, Paola},
  title = {Detection of TDP‐43 seeds in CSF of presymptomatic and symptomatic genetic FTD/ALS},
  journal = {Alzheimer's & Dementia},
  year = {2025},
  doi = {10.1002/alz.70989}
}
Kostenlos starten →